Jodi Clyde-Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jodi Clyde-Smith has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- John F. Hancock
Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, USA
5 shared publications Ann Apolloni
From the ‡Queensland Cancer Fund Laboratory of Experimental Oncology, Department of Pathology, University of Queensland Medical School, Herston Road, Brisbane 4006, Queensland and the §Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, Bancroft Centre, Herston Road, Brisbane 4006, Queensland, Australia
2 shared publications- Jun Yan
Department of Internal Medicine ‑ Oncology, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China
2 shared publications Sandrine Roy
From the Institute for Molecular Bioscience, Centre for Microscopy and Microanalysis, and School of Biomedical Sciences, University of Queensland, Brisbane 4072, Australia and the §Queensland Cancer Fund Laboratory of Experimental Oncology, Department of Pathology, University of Queensland Medical School, Herston Road, Brisbane 4006, Australia
2 shared publications- Albert Pol
Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). 08036, Barcelona, Spain; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain
1 shared publication Amanda J. Carozzi
Institute for Molecular Bioscience, Centre for Microscopy and Microanalysis, and School of Biomedical Sciences, University of Queensland, Brisbane 4072, Australia
1 shared publication
Latest Publications
- 29 April 2024
- Published by University of Queensland Library
Characterization of ras isoform activation by ras guanine nucleotide exchange factors
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- 29 April 2024
- Published by University of Queensland Library
Characterization of ras isoform activation by ras guanine nucleotide exchange factors
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- 4 May 2014
- Published by Taylor & Francis in Journal of Higher Education Policy and Management
- Vol. 36 (3) , 327-337
Utilising enterprise risk management strategies to develop a governance and operations framework for a new research complex: a case study
Enterprise risk management strategies were used to develop a regulatory and operational framework for a new multi-partner Research Institute that will house up to 900 staff from four different institutions in Queensland, Australia. The Institute will operate in a business environment while functioning as a research resource for the higher education sector. Enterprise risk management strategies were used to develop a regulatory and operational framework to support the Institute in achieving its vision, maximising opportunities, minimising risk and providing an environment conducive to research collaboration.
- 4 May 2014
- Published by Taylor & Francis in Journal of Higher Education Policy and Management
- Vol. 36 (3) , 327-337
Utilising enterprise risk management strategies to develop a governance and operations framework for a new research complex: a case study
Enterprise risk management strategies were used to develop a regulatory and operational framework for a new multi-partner Research Institute that will house up to 900 staff from four different institutions in Queensland, Australia. The Institute will operate in a business environment while functioning as a research resource for the higher education sector. Enterprise risk management strategies were used to develop a regulatory and operational framework to support the Institute in achieving its vision, maximising opportunities, minimising risk and providing an environment conducive to research collaboration.
- 18 May 2008
- Published by Springer Nature in Nature Cell Biology
- Vol. 10 (6) , 740-747
An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway
The growth and metabolic actions of growth hormone (GH) are believed to be mediated through the GH receptor (GHR) by JAK2 activation. The GHR exists as a constitutive homodimer, with signal transduction by ligand-induced realignment of receptor subunits. Based on the crystal structures, we identify a conformational change in the F'G' loop of the lower cytokine module, which results from binding of hGH but not G120R hGH antagonist. Mutations disabling this conformational change cause impairment of ERK but not JAK2 and STAT5 activation by the GHR in FDC-P1 cells. This results from the use of two associated tyrosine kinases by the GHR, with JAK2 activating STAT5, and Lyn activating ERK1/2. We provide evidence that Lyn signals through phospholipase C gamma, leading to activation of Ras. Accordingly, mice with mutations in the JAK2 association motif respond to GH with activation of hepatic Src and ERK1/2, but not JAK2/STAT5. We suggest that F'G' loop movement alters the signalling choice between JAK2 and a Src family kinase by regulating TMD realignment. Our findings could explain debilitated ERK but not STAT5 signalling in some GH-resistant dwarfs and suggest pathway-specific cytokine agonists.
- 18 May 2008
- Published by Springer Nature in Nature Cell Biology
- Vol. 10 (6) , 740-747
An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway
The growth and metabolic actions of growth hormone (GH) are believed to be mediated through the GH receptor (GHR) by JAK2 activation. The GHR exists as a constitutive homodimer, with signal transduction by ligand-induced realignment of receptor subunits. Based on the crystal structures, we identify a conformational change in the F'G' loop of the lower cytokine module, which results from binding of hGH but not G120R hGH antagonist. Mutations disabling this conformational change cause impairment of ERK but not JAK2 and STAT5 activation by the GHR in FDC-P1 cells. This results from the use of two associated tyrosine kinases by the GHR, with JAK2 activating STAT5, and Lyn activating ERK1/2. We provide evidence that Lyn signals through phospholipase C gamma, leading to activation of Ras. Accordingly, mice with mutations in the JAK2 association motif respond to GH with activation of hepatic Src and ERK1/2, but not JAK2/STAT5. We suggest that F'G' loop movement alters the signalling choice between JAK2 and a Src family kinase by regulating TMD realignment. Our findings could explain debilitated ERK but not STAT5 signalling in some GH-resistant dwarfs and suggest pathway-specific cytokine agonists.
- Open Access
- 1 May 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (20) , 17944-17949
Inhibition of Lipid Raft-dependent Signaling by a Dystrophy-associated Mutant of Caveolin-3
- 1 May 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (20) , 17944-17949
Open AccessInhibition of Lipid Raft-dependent Signaling by a Dystrophy-associated Mutant of Caveolin-3
- Open Access
- 1 January 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (1) , 272-278
The Linker Domain of the Ha-Ras Hypervariable Region Regulates Interactions with Exchange Factors, Raf-1 and Phosphoinositide 3-Kinase
- 1 January 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (1) , 272-278
Open AccessThe Linker Domain of the Ha-Ras Hypervariable Region Regulates Interactions with Exchange Factors, Raf-1 and Phosphoinositide 3-Kinase
- Open Access
- 1 October 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (41) , 32260-32267
Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor
- 1 October 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (41) , 32260-32267
Open AccessCharacterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor
- 1 July 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (7) , 3947-3955
14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo
14-3-3 proteins complex with many signaling molecules, including the Raf-1 kinase. However, the role of 14-3-3 in regulating Raf-1 activity is unclear. We show here that 14-3-3 is bound to Raf-1 in the cytosol but is totally displaced when Raf-1 is recruited to the plasma membrane by oncogenic mutant Ras, in vitro and in vivo. 14-3-3 is also displaced when Raf-1 is targeted to the plasma membrane. When serum-starved cells are stimulated with epidermal growth factor, some recruitment of 14-3-3 to the plasma membrane is evident, but 14-3-3 recruitment correlates with Raf-1 dissociation and inactivation, not with Raf-1 recruitment. In vivo, overexpression of 14-3-3 potentiates the specific activity of membrane-recruited Raf-1 without stably associating with the plasma membrane. In vitro, Raf-1 must be complexed with 14-3-3 for efficient recruitment and activation by oncogenic Ras. Recombinant 14-3-3 facilitates Raf-1 activation by membranes containing oncogenic Ras but reduces the amount of Raf-1 that associates with the membranes. These data demonstrate that the interaction of 14-3-3 with Raf-1 is permissive for recruitment and activation by Ras, that 14-3-3 is displaced upon membrane recruitment, and that 14-3-3 may recycle Raf-1 to the cytosol. A model that rationalizes many of the apparently discrepant observations on the role of 14-3-3 in Raf-1 activation is proposed.
- 1 July 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (7) , 3947-3955
14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo
14-3-3 proteins complex with many signaling molecules, including the Raf-1 kinase. However, the role of 14-3-3 in regulating Raf-1 activity is unclear. We show here that 14-3-3 is bound to Raf-1 in the cytosol but is totally displaced when Raf-1 is recruited to the plasma membrane by oncogenic mutant Ras, in vitro and in vivo. 14-3-3 is also displaced when Raf-1 is targeted to the plasma membrane. When serum-starved cells are stimulated with epidermal growth factor, some recruitment of 14-3-3 to the plasma membrane is evident, but 14-3-3 recruitment correlates with Raf-1 dissociation and inactivation, not with Raf-1 recruitment. In vivo, overexpression of 14-3-3 potentiates the specific activity of membrane-recruited Raf-1 without stably associating with the plasma membrane. In vitro, Raf-1 must be complexed with 14-3-3 for efficient recruitment and activation by oncogenic Ras. Recombinant 14-3-3 facilitates Raf-1 activation by membranes containing oncogenic Ras but reduces the amount of Raf-1 that associates with the membranes. These data demonstrate that the interaction of 14-3-3 with Raf-1 is permissive for recruitment and activation by Ras, that 14-3-3 is displaced upon membrane recruitment, and that 14-3-3 may recycle Raf-1 to the cytosol. A model that rationalizes many of the apparently discrepant observations on the role of 14-3-3 in Raf-1 activation is proposed.